LinkOPH

CHICAGO — At the Ophthalmology Innovation Summit here, Jai Parekh, MD, discusses a functionalized nano particle delivery system in development.

Read more →

CHICAGO — At the Ophthalmology Innovation Summit here, Eliot J. Lazar, MD, discusses the importance of the Ophthalmology Innovation Summit within the ophthalmic community.

Read more →

I had the exciting experience of being involved in organizing the Young Ophthalmologists (YO) sessions at the Nordic Congress of Ophthalmology (NOK) in Stockholm. It was the first time we were given the space to hold our own sessions. The idea came from Stefan Seregard, MD, PhD, president of the European Society of Ophthalmology (SOE), who is a wonderful advocate of YO.At the time of the SOE congress in Copenhagen, I discussed possibilities with Anthony Khawaja, current chair of SOE YO. Anthony and I brainstormed and decided what topics should (Read more...)

CHICAGO — A new anti-VEGF indicated for use in wet age-related macular degeneration achieved clinically meaningful and durable vision improvement in several studies with reduced dosing, according to a speaker here.Conbercept, a fusion protein produced in a manner similar to Elyea (aflibercept, Regeneron) is approved for use in China, and discussions are underway to bring this drug to the U.S. and other countries, Peter K. Kaiser, MD, told colleagues at the Retina Subspecialty Day preceding the American Academy of Ophthalmology meeting.

Read more →